| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/03/2011 | WO2011024955A1 Nucleic acid capable of binding to tgf-βii-type receptor, and use thereof |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011024874A1 Base addition salts |
| 03/03/2011 | WO2011024056A2 An improved process for the preparation of bosentan |
| 03/03/2011 | WO2011023812A1 Microsomal prostaglandin e synthase-1 (mpges1) inhibitors |
| 03/03/2011 | WO2011023693A1 Methylpyrrolopyrimidinecarboxamides |
| 03/03/2011 | WO2008065408A9 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110054032 Dioxoanthracene sulphonate derivatives |
| 03/03/2011 | US20110054017 Substituted furans and their use |
| 03/03/2011 | US20110053986 Respiratory disease treatment |
| 03/03/2011 | US20110053983 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 03/03/2011 | US20110053969 Novel diazasipiroakanes and their use for treatment of ccr8 mediated diseases |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury |
| 03/03/2011 | US20110053952 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| 03/03/2011 | US20110053940 3,4-substituted piperidine derivatives as renin inhibitors |
| 03/03/2011 | US20110053939 Novel aromatic nitro compounds |
| 03/03/2011 | US20110053926 New Pharmaceutically-Active Compounds for the Treatment of Respiratory Diseases |
| 03/03/2011 | US20110053909 Compounds - 801 |
| 03/03/2011 | US20110053897 Compounds and compositions as syk kinase inhibitors |
| 03/03/2011 | US20110053896 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 03/03/2011 | US20110053893 Compounds and compositions as tlr activity modulators |
| 03/03/2011 | US20110053876 macrolides and their use |
| 03/03/2011 | US20110053875 Macrolide synthesis process and solid-state forms |
| 03/03/2011 | US20110053853 Use of copolymer 1 for treatment of muscular dystrophy |
| 03/03/2011 | US20110053831 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith |
| 03/03/2011 | US20110052729 Pharmaceutical or nutraceutical composition |
| 03/03/2011 | US20110052689 Sustained release of guaifenesin |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052601 Compositions comprising anti-icam-1 antibodies |
| 03/03/2011 | US20110052598 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 03/03/2011 | US20110052597 Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof |
| 03/03/2011 | US20110052585 Compositions and methods for inhibiting interleukin pathways |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110052560 Method for Increasing the Activity of the Immune System of a Mammal at Risk of Inflammatory Diseases |
| 03/03/2011 | US20110052535 Compositions for treating an inflammatory autoimmune condition |
| 03/03/2011 | DE102009037089A1 Zusammensetzung mit Stämmen von Lactobazillus fermentum Composition with Lactobacillus fermentum strains of |
| 03/03/2011 | CA2771938A1 Methylpyrrolopyrimidinecarboxamides |
| 03/03/2011 | CA2771215A1 Therapeutic preparation for rhinitis |
| 03/02/2011 | EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289550A2 Ultra high affinity neutralizing antibodies |
| 03/02/2011 | EP2289531A2 Medicaments for increasing endogenous erythropoietine (EPO) |
| 03/02/2011 | EP2289508A1 Combined treatment for lung cancer |
| 03/02/2011 | EP2289503A2 Treating muscle wasting with selective androgen receptor modulators |
| 03/02/2011 | EP2289499A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 03/02/2011 | EP2288414A1 Anhydrous and hydrate forms of crystalline 2- ( (2s, 3r, 4e, 6e, 1oe, 12s) -13- (4-fluorophenoxy) -2,3, 12- (trihydroxytrideca-4, 6, 10-trien-8-ynyl) oxy) acetic acid |
| 03/02/2011 | EP1833502B1 Pharmaceutical composition for the treatment of invasive pulmonary aspergillosis |
| 03/02/2011 | EP1831174B1 Amide derivatives |
| 03/02/2011 | EP1646656B1 Human antibody molecules for il-13 |
| 03/02/2011 | EP1638552B1 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer |
| 03/02/2011 | CN101983060A Methods and compositions for treating respiratory disease |
| 03/02/2011 | CN101982196A Traditional Chinese medicine composition for treating lung cancer, preparation method and application thereof |
| 03/02/2011 | CN101982190A External cream for treating wind cold by utilizing percutaneous absorption technology |
| 03/02/2011 | CN101982184A Preparation method of taraxacum extract |
| 03/02/2011 | CN101982179A Xiao er Anfen Huang Namin granule and preparation method thereof |
| 03/02/2011 | CN101982174A Formula of compound medicine preparation for relieving cough and preventing asthma and preparation method thereof |
| 03/02/2011 | CN101084889B Ginkgolide freezing-dried powder injection and preparation method thereof |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897646 Use for budesonide and formoterol |
| 03/01/2011 | US7897644 Antiinflammatory agents; analgesics |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897617 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/01/2011 | US7897610 Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction |
| 03/01/2011 | US7897346 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897173 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 02/24/2011 | WO2011022449A1 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones |
| 02/24/2011 | WO2011022075A1 Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease |
| 02/24/2011 | WO2011021833A2 Composition for preventing or treating inflammation |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021645A1 Bicyclic urea derivative or pharmacologically permitted salt thereof |
| 02/24/2011 | WO2011021203A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | WO2010087980A3 Bicyclic amide derivatives for the treatment of respiratory depression |
| 02/24/2011 | US20110046546 Methods for treating headaches |
| 02/24/2011 | US20110046237 Compounds with activity at estrogen receptors |
| 02/24/2011 | US20110046202 Method for testing a subject thought to have or to be predisposed to asthma |
| 02/24/2011 | US20110046191 Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist |
| 02/24/2011 | US20110046170 Novel pyrimidine-pyridine derivatives |
| 02/24/2011 | US20110046168 Methods of treating diseases using quinazoline derivatives and pharmaceutical compositions containing them |
| 02/24/2011 | US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists |
| 02/24/2011 | US20110046158 Capped pyrazinoylguanidine sodium channel blockers |
| 02/24/2011 | US20110046150 Use of n--4-(3-pyridyl)-2-pyridine-amine for the treatment of pulmonary hypertension |
| 02/24/2011 | US20110046142 Antibiotic compounds |
| 02/24/2011 | US20110046136 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associcated therewith |
| 02/24/2011 | US20110046131 Purines as pkc-theta inhibitors |
| 02/24/2011 | US20110046130 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
| 02/24/2011 | US20110046118 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | US20110046078 Methods and compositions for treating diseases and disorders associated with siglec-8 |
| 02/24/2011 | US20110046069 Uses of Modified ELR-CXC Chemokine G31P |
| 02/24/2011 | US20110045086 Steroid Nebuliser Formulation |
| 02/24/2011 | US20110045045 Production of and uses for decellularized lung tissue |
| 02/24/2011 | US20110045032 Composition, formulations & kit for treatment of respiratory and lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |